J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 681.95 INR -1.94%
Market Cap: 261.2B INR
Have any thoughts about
J B Chemicals and Pharmaceuticals Ltd?
Write Note

J B Chemicals and Pharmaceuticals Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

J B Chemicals and Pharmaceuticals Ltd
Depreciation & Amortization Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Depreciation & Amortization
â‚ą1.4B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Depreciation & Amortization
â‚ą14.7B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Depreciation & Amortization
â‚ą10.4B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Depreciation & Amortization
â‚ą25.5B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Depreciation & Amortization
â‚ą8.1B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Depreciation & Amortization
â‚ą4B
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is J B Chemicals and Pharmaceuticals Ltd's Depreciation & Amortization?
Depreciation & Amortization
1.4B INR

Based on the financial report for Jun 30, 2024, J B Chemicals and Pharmaceuticals Ltd's Depreciation & Amortization amounts to 1.4B INR.

What is J B Chemicals and Pharmaceuticals Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
26%

Over the last year, the Depreciation & Amortization growth was 21%. The average annual Depreciation & Amortization growth rates for J B Chemicals and Pharmaceuticals Ltd have been 26% over the past three years .

Back to Top